Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Change in Cash: 2021-2025

Historic Change in Cash for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to -$3.8 billion.

  • Roivant Sciences' Change in Cash rose 99.96% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 billion, marking a year-over-year decrease of 2276.43%. This contributed to the annual value of -$3.8 billion for FY2025, which is 178.73% down from last year.
  • As of FY2025, Roivant Sciences' Change in Cash stood at -$3.8 billion, which was down 178.73% from $4.9 billion recorded in FY2024.
  • Roivant Sciences' 5-year Change in Cash high stood at $4.9 billion for FY2024, and its period low was -$3.8 billion during FY2025.
  • Over the past 3 years, Roivant Sciences' median Change in Cash value was -$381.9 million (recorded in 2023), while the average stood at $217.2 million.
  • As far as peak fluctuations go, Roivant Sciences' Change in Cash tumbled by 464.62% in 2023, and later spiked by 1,372.09% in 2024.
  • Roivant Sciences' Change in Cash (Yearly) stood at -$127.6 million in 2021, then soared by 46.98% to -$67.6 million in 2022, then plummeted by 464.62% to -$381.9 million in 2023, then spiked by 1,372.09% to $4.9 billion in 2024, then slumped by 178.73% to -$3.8 billion in 2025.